Association of a Smartphone Application With Medication Adherence and Blood Pressure Control

Abstract

IMPORTANCE Medication nonadherence accounts for up to half of uncontrolled hypertension. Smartphone applications (apps) that aim to improve adherence are widely available but have not been rigorously evaluated.OBJECTIVE To determine if the Medisafe smartphone app improves self-reported medication adherence and blood pressure control. DESIGN, SETTING, AND PARTICIPANTSThis was a 2-arm, randomized clinical trial (Medication Adherence Improvement Support App For Engagement-Blood Pressure [MedISAFE-BP]). Participants were recruited through an online platform and were mailed a home blood pressure cuff to confirm eligibility and to provide follow-up measurements. Of 5577 participants who were screened, 412 completed consent, met inclusion criteria (confirmed uncontrolled hypertension, taking 1 to 3 antihypertensive medications), and were randomized in a ratio of 1:1 to intervention or control.INTERVENTIONS Intervention arm participants were instructed to download and use the Medisafe app, which includes reminder alerts, adherence reports, and optional peer support. MAIN OUTCOMES AND MEASURESCo-primary outcomes were change from baseline to 12 weeks in self-reported medication adherence, measured by the Morisky medication adherence scale (MMAS) (range, 0-8, with lower scores indicating lower adherence), and change in systolic blood pressure.RESULTS Participants (n = 411; 209 in the intervention group and 202 controls) had a mean age of 52.0 years and mean body mass index, calculated as weight in kilograms divided by height in meters squared, of 35.5; 247 (60%) were female, and 103 (25%) were black. After 12 weeks, the mean (SD) score on the MMAS improved by 0.4 (1.5) among intervention participants and remained unchanged among controls (between-group difference: 0.4; 95% CI, 0.1-0.7; P = .01). The mean (SD) systolic blood pressure at baseline was 151.4 (9.0) mm Hg and 151.3 (9.4) mm Hg, among intervention and control participants, respectively. After 12 weeks, the mean (SD) systolic blood pressure decreased by 10.6 (16.0) mm Hg among intervention participants and 10.1 (15.4) mm Hg among controls (between-group difference: −0.5; 95% CI, −3.7 to 2.7; P = .78).CONCLUSIONS AND RELEVANCE Among individuals with poorly controlled hypertension, patients randomized to use a smartphone app had a small improvement in self-reported medication adherence but no change in systolic blood pressure compared with controls. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT02727543

Multicentre cohort study of antihypertensive and lipid-lowering therapy cessation after bariatric surgery

“…They may have been overestimated, as patients may not seek further medical follow-up after bariatric surgery, and may stop taking treatments despite persistent hypertension or high lipid levels. However, the same pattern is likely to occur in the control group, with obese patients not continuing to seek medical help, suggesting that the present comparisons are valid 33 .…”

Validation of a novel smartphone application‐enabled, patient‐operated skin barrier device

“…Several specialties across medicine are exploring this new communication mode to improve adherence and patient‐reported outcomes. Smartphone application use has been associated with an increase in medication adherence, enhanced sun protective behaviors, and improved post‐operative patient‐reported outcomes . GPower's application‐based take‐home technology could improve adherence by offering patients real‐time skin barrier function information.…”

The Impact of the Virtual Cognitive Health Program on the Cognition and Mental Health of Older Adults: Pre-Post 12-Month Pilot Study (Preprint)

“…A number of prospective clinical studies have been previously conducted to measure the impact of digital solutions on chronic disease prevention and management; [36][37][38][39] however there have been a limited number of studies and solutions focused on older adults. In this study we observed high compliance and engagement with study-related activities (e.g., completion of RBANS tests, online assessments) and high engagement and satisfaction with the digital technology-based VC Health program for a population of older at-risk adults with SCD.…”